Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity-Reference-Cited by-同舟云学术

Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity

Published:2018-02-27 Issue:9 Volume:38 Page:1166-1176
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J Appl Toxicol

Author:

Yang Xi¹^ORCID,Papoian Thomas¹

Affiliation:

1. Center for Drug Evaluation and Research, FDA; 10903 New Hampshire Ave Silver Spring MD 20993 USA

Publisher

Wiley

Subject

Toxicology

Reference81 articles.

1. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes;Ando;Journal of Pharmacological and Toxicological Methods,2017

2. Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling;Babiarz;Stem Cells and Development,2012

3. Technological advances in cardiovascular safety assessment decrease preclinical animal use and improve clinical relevance;Berridge;ILAR Journal,2016

4. Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias;Blinova;Toxicological Sciences,2017

5. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling;Bowes;Nature Reviews. Drug Discovery,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Cardiovascular Toxicity Screening: Integrating Human iPSC-Derived Cardiomyocytes with In Silico Models;2024-06-22

2. Prediction of Cardiac Toxicity by Anti-cancer Drugs Using iPSC Cardiomyocytes;YAKUGAKU ZASSHI;2024-03-01

3. Cardiotoxicity risk assessment of anti-cancer drugs and future perspectives;Folia Pharmacologica Japonica;2024-03-01

4. Enhancing cardiomyocytes contraction force measuring in drug testing: Integration of a highly sensitive single-crystal silicon strain sensor into SU-8 cantilevers;Biosensors and Bioelectronics;2024-01

5. Drug Development Using Human iPSC-Derived Cardiomyocytes and Future Perspectives;Reference Module in Biomedical Sciences;2024